Patents by Inventor Peter De Waele

Peter De Waele has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKER METHODS AND COMPOSITIONS
    Publication number: 20150337031
    Abstract: Antibodies are provided that bind selectively to MEF2C (Myocyte-specific enhancer factor 2C)—also known as MADS box transcription enhancer factor 2, polypeptide C. MEF2C is one of several biomarkers expressed in committed cells differentiated from stem cells. MEF2C is a transcription factor in the MEF2 family of proteins, which play a role in cardiac morphogenesis, myogenesis and also vascular development. Also provided are hybridoma that produces the antibodies, as well as methods of use and kits for using the antibodies for diagnostic and therapeutic purposes.
    Type: Application
    Filed: December 19, 2013
    Publication date: November 26, 2015
    Inventors: Sebastien MAUEN, Peter DE WAELE, Roldand GORDON-BERESFORD
  • Cryopreservation of adipose tissue for the isolation of mesenchymal stem cells
    Patent number: 8481253
    Abstract: The present invention relates to a method and composition for the cryopreservation of adipose tissue with the intention to use this tissue in the culturing of stem and/or progenitor cells. The method uses a specific cryoprotection medium to prevent damage of the original tissue during the cryopreservation while still maintaining a high viability of the stem and/or progenitor cells obtained from the cryopreserved adipose tissue. Furthermore the cryoprotection medium of the present invention does not contain any kind of xenogeneic sera, a critical factor since it is the intention of that the cryopreserved tissue is used for obtaining stem and/or progenitor cells that can be used in medicine. The cryoprotection medium is characterized in that it is a solution of physiological water comprising glycerol and sucrose and/or trehalose and optionally serum albumin.
    Type: Grant
    Filed: March 19, 2009
    Date of Patent: July 9, 2013
    Assignee: Cryo-Save AG
    Inventors: Guy Wouters, Kelly van Wemmel, Peter de Waele
  • Cryopreservation of Adipose Tissue for the Isolation of Mesenchymal Stem Cells
    Publication number: 20110008300
    Abstract: The present invention relates to a method and composition for the cryopreservation of adipose tissue with the intention to use this tissue in the culturing of stem and/or progenitor cells. The method uses a specific cryoprotection medium to prevent damage of the original tissue during the cryopreservation while still maintaining a high viability of the stem and/or progenitor cells obtained from the cryopreserved adipose tissue. Furthermore the cryoprotection medium of the present invention does not contain any kind of xenogeneic sera, a critical factor since it is the intention of that the cryopreserved tissue is used for obtaining stem and/or progenitor cells that can be used in medicine. The cryoprotection medium is characterized in that it is a solution of physiological water comprising glycerol and sucrose and/or trehalose and optionally serum albumin.
    Type: Application
    Filed: March 19, 2009
    Publication date: January 13, 2011
    Applicant: CRYO-SAVE AG
    Inventors: Guy Wouters, Kelly van Wemmel, Peter de Waele
  • Pharmaceutical compositions of cell lysate and processes for the production and use thereof
    Patent number: 7264826
    Abstract: The present invention relates to a pharmaceutical composition comprising a non-viable cell lysate and at least one antiflocculant and/or antisedimentation agent(s). The pharmaceutical composition of the present invention comprising the cell lysate is in the form of a solution or a suspension or a lyophilisate, in particular, the homogenized cell lysate compositions are in the form of solutions or suspensions or lyophilisates. The present invention further discloses processes for the production and the use of the pharmaceutical composition.
    Type: Grant
    Filed: November 25, 2003
    Date of Patent: September 4, 2007
    Assignee: CellTran Limited
    Inventors: Chris Vervaet, Jean-Paul Remon, Bernard Delaey, Peter De Waele
  • Pharmaceutical compositions of cell lysate and processes for the production and use thereof
    Publication number: 20060039989
    Abstract: The present invention relates to a pharmaceutical composition comprising a non-viable cell lysate and at least one antiflocculant and/or antisedimentation agent(s). The pharmaceutical composition of the present invention comprising the cell lysate is in the form of a solution or a suspension or a lyophilisate, in particular, the homogenized cell lysate compositions are in the form of solutions or suspensions or lyophilisates. The present invention further discloses processes for the production and the use of the pharmaceutical composition.
    Type: Application
    Filed: November 25, 2003
    Publication date: February 23, 2006
    Applicant: Innogenetics N.V.
    Inventors: Chris Vervaet, Jean-Paul Remon, Bernard Delaey, Peter De Waele
  • Wound healing compositions and uses
    Publication number: 20050079147
    Abstract: The present invention relates to poloxamer compositions and the use thereof for the purpose of treating skin wounds on a human body.
    Type: Application
    Filed: December 23, 2003
    Publication date: April 14, 2005
    Inventors: Bernard Delaey, Peter De Waele